Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Ridgetech's Enterprise Value is €-7.2 Mil.
Ridgetech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was €14.9 Mil. Therefore, Ridgetech's EV-to-OCF for today is -0.48.
The historical rank and industry rank for Ridgetech's EV-to-OCF or its related term are showing as below:
FRA:7QL'
s EV-to-OCF Range Over the Past 10 Years
Min: -1049.44 Med: -7.41 Max: 38.31
Current: -0.49
During the past 13 years, the highest EV-to-OCF of Ridgetech was 38.31. The lowest was -1049.44. And the median was -7.41.
FRA:7QL's EV-to-OCF is ranked better than 72.43% of 682
companies
in the Healthcare Providers & Services industry
Industry Median: 8.665
vs FRA:7QL: -0.49
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ridgetech's share price for today is €20304.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ridgetech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €312.297.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ridgetech EV-to-OCF Related Terms
Ridgetech EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Ridgetech's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Ridgetech's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ridgetech EV-to-OCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ridgetech's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Ridgetech's EV-to-OCF falls into.
Ridgetech's current Enterprise Value is €-7.2 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ridgetech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Sep. 2025 was €14.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ridgetech (FRA:7QL) has a EV-to-OCF of -0.48 as of Jul. 25, 2026. According to the industry distribution chart, Ridgetech ranks #188 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 27.6%.
Is Ridgetech's EV-to-OCF too high?
Ridgetech's current EV-to-OCF is -0.48. Based on the distribution chart, Ridgetech ranks #188 out of 682 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ridgetech has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Ridgetech's EV-to-OCF compare to DHTI and PMHS?
According to the Healthcare Providers & Services industry distribution chart, Ridgetech ranks #188 out of 682 companies for EV-to-OCF. This puts Ridgetech in the upper half of its industry. The industry median EV-to-OCF is 8.67. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Healthcare Providers & Services company?
The median EV-to-OCF among Healthcare Providers & Services companies is 8.67, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median EV-to-OCF is 8.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ridgetech's current EV-to-OCF is -0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ridgetech stock overvalued right now?
Ridgetech (FRA:7QL) has a current EV-to-OCF of -0.48. The stock's GF Value™ is €2,118,249.18, compared to a current price of €20,304.00 — trading 99% below its estimated fair value. The current EV-to-OCF is -0.48. Ridgetech's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Ridgetech (FRA:7QL), the current EV-to-OCF is -0.48 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ridgetech (FRA:7QL) Overvalued in 2026?
Based on GuruFocus' analysis, Ridgetech stock appears to be undervalued.
The current stock price of €20,304.00 is trading 99% below its estimated GF Value™ of €2,118,249.18.
Key valuation signals for FRA:7QL:
EV-to-OCF: -0.48
GF Value™: €2,118,249.18 vs. price of €20,304.00 (99% below fair value)
No single metric tells the full story. See the FRA:7QL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
40GF Score
Get the complete analysis for FRA:7QL
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7QL has been successfully added to your 
